EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging
Clinical data to date shows efti uniquely positioned to address entire NSCLC patient population through both chemo-free IO-IO and IO-IO-chemo triple combinations
Getinge has a strong market share in India within several product segments
SVB Financial Group and its subsidiaries were involved in over $1.4 billion in total venture financing raised from 2010 to 2022 for drug development
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
70+ CXOs from leading healthcare institutions across India attended the confluence at Mumbai
Loperamide Hydrochloride Capsules USP, 2 mg had annual sales of US $34.7 million in the United States
The event witnessed a historic journey of Thalassemics India gracing the theme “LAKSH”
The award recognizes and supports promising female scientists working in mass spectrometry
Subscribe To Our Newsletter & Stay Updated
